21 American Tourists Infected with Rare Virus After Vacationing in Cuba, 3 Hospitalized! Is Cuba's Economic Crisis Creating a Breeding Ground for Viruses?
As of August 16, 2023, the U.S. Centers for Disease Control and Prevention (CDC) noted in its most recent report that there were 21 confirmed cases of Oropouche infection in U.S. travelers after returning from Cuba. The Oropouche virus is a virus spread mainly through the bite of a specific species of mosquito. Typical symptoms include headache, fever, muscle pain and joint pain. Fortunately, the virus does not usually kill those infected. Most of the cases occurred between May and July, with three patients requiring hospitalization for symptoms so severe, but there have been no deaths, according to the CDC.
It is worth noting that Cuba is currently facing a severe economic crisis, which makes it even more difficult to contain the spread of the virus. Cuba has encountered difficulties in implementing anti-mosquito measures due to unstable electricity supplies and fuel shortages. The Cuban Health Ministry also reported that there have been more than 400 cases of Oropouche this year, especially in urban centers such as Havana, where the number of cases has risen.
In light of the situation, the Centers for Disease Control and Prevention has issued a health alert alerting residents of the Americas region to the increasing number of Oropouche cases. At present, the medical community has not developed a specific treatment or vaccine against Oropouche virus, so preventive measures are particularly important. Visitors and local residents should take necessary protective measures, such as using mosquito repellent, wearing long-sleeved clothing and trousers, to reduce the risk of mosquito bites.
Looking for chemical products? Let suppliers reach out to you!
2026-07-13
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
U.S. API Dependence Turns Pharmaceutical Ingredients Into a National Security Issue
-
Pharma Tariff Risk Pushes Global Drugmakers to Rebuild U.S. Supply Chains
-
The GLP-1 Sweet Shot in India’s Diabetic Gut
-
Small Pharma Firms Under Threat as Regulator Tightens Quality Norms
-
Merck Nears Acquisition of Cidara to Strengthen Flu Prevention Arsenal
-
Biocon Weighs Merger of Biocon Biologics to Unlock Value
-
After Semaglutide Patent Expiry in India, the Price System Has Been Restructured as More Than 40 Drugmakers Enter the Competition
-
Sun Pharma’s Utreglutide Shows Promising Weight Loss and Liver Fat Reduction
-
Betting on Next-Generation Metabolic Therapies: Pfizer’s Big Wager on Metsera and Its Strategic Reshaping in China
-
India Targets Fake Drug Packaging
Recommend Reading
-
Eli Lilly to Raise UK Mounjaro Price 170 Percent Monthly Cost Jumps from £122 to £330
-
FDA Approves Precigen’s Papzimeos Immunotherapy 51 Percent of RRP Patients Avoid Surgery for One Year
-
Eli Lilly Strikes $1.3 Billion AI Deal with Superluminal for Next-Gen Obesity Drugs Targets GPCR Breakthrough
-
Sun Pharma’s Ilumya Hits Primary Endpoint in Two Phase 3 Trials for Psoriatic Arthritis $681 Million Drug Shows Significant Improvement at Week 24
-
Novo Nordisk Launches Wegovy in South Africa One in Two Adults Faces Obesity as GLP-1 Drug Competition Heats Up
-
July China Maleic Anhydride Market Continues Downward Trend
-
Supply and Demand Weakness Leads to Downward Trend in Butadiene Market
-
January China's bunker fuel market fluctuates
-
Coke Market Prices Remain Stable with a Rising Trend
-
Recent Maleic Anhydride Market Trend Consolidation in China